Toxic shock syndrome toxin 1 (TSST1)t is a 22-kD exotoxin produced by most strains of Staphylococcus aureus isolated from patients with toxic shock syndrome (TSS) (1) . TSST 1 is a potent activator of monocytes and T cells . It acts on monocytes to induce the synthesis of IL-1 and TNF (2-4) . TSSTl also triggers T cell activation and proliferation (5), as well as the production of large amounts of various lymphokines such as IL-2 (6) and IFN-y (7) . The massive induction of monokine and lymphokine production by TSST1 is thought to play an important role in the pathogenesis of TSS.A significant insight into the mechanism of action of TSST 1, as well as other related staphylococcal exotoxins, came with the observation that these toxins bind directly to MHC class II molecules (8-11). Among the MHC class II molecules, TSST1 binds equally well with high affinity and saturation kinetics to HLA-DR and -DQ antigens (8) . TSST 1 also binds to HLA-DP alleles, albeit with a much lower affinity than is observed for HLA-DR and -DQalleles (Scholl, P, unpublished data) . The MHC class II-bound toxin behaves as a superantigen that interacts with T cells via the TCR )3 chain (12, 13) to induce MHC-unrestricted T cell activation and proliferation .The ability ofMHC class II-bound TSST1 to engage T cells raises the possibility that TSST 1 may mimic nominal antigen in initiating cognate interaction between T and B cells resulting in B cell proliferation and Ig production . We demonstrate here that TSST1 induces both the proliferation of resting human B cells and their differentiation into Ig-secreting lymphocytes . Triggering of B cell proliferation and differentiation by TSST1 is dependent on the presence of T cells, and proceeds via This work was supported by U. S .